Abbott Sees Opportunity In Foreign Income Repatriation Bill
This article was originally published in The Tan Sheet
Executive Summary
Legislation pending in Congress to allow repatriation of overseas income is an "interesting opportunity," Abbott Chief Financial Officer Thomas Freyman said during an Oct. 9 conference call
You may also be interested in...
Merck Sees Chance To “Repatriate” Cash To U.S.; GSK Wants To Ship Out
Merck sees an opportunity to bring back cash to the U.S. should a tax change allowing companies to "repatriate" holdings at foreign subsidiaries be enacted by Congress this year
Merck Sees Chance To “Repatriate” Cash To U.S.; GSK Wants To Ship Out
Merck sees an opportunity to bring back cash to the U.S. should a tax change allowing companies to "repatriate" holdings at foreign subsidiaries be enacted by Congress this year
Foreign Cash Repatriation Bill Can Pass If Tied To Jobs, Breaux Tells PhRMA
Legislation to allow pharmaceutical companies to transfer cash held by overseas affiliates to the U.S. has a chance to pass Congress this year - if the bill ensures that proceeds are devoted to the creation of new jobs, Sen. John Breaux (D-La.) told the Pharmaceutical Research & Manufacturers of America annual meeting April 3 in Palm Beach, Fla